Dr. Trinanjan Basu

   MBBS, MD (Radiation Oncology), Fellow of ESCO (European school of Oncology)

Book An Appointment

Home / Doctors / Dr. Trinanjan Basu

Dr. Trinanjan Basu

Senior Consultant - Radiation Oncologist


MBBS, MD (Radiation Oncology), Fellow of ESCO (European school of Oncology)


Radiation Oncology


HCG Cancer Centre - Borivali


14 Years

  • Dr. Basu's areas of expertise include treatment of head & neck cancers with IMRT/VMAT, and the application of SRS/SBRT in brain, spine, lung and prostate malignancies.
  • He is experienced in PET-CT-based treatment planning and evaluation for head & neck malignancies, better techniques to spare normal structures and assess and improve quality of life.
  • His future ambitions include analysing and documenting contemporary imaging-based outcome analysis (PET-CT and MRI) for diverse cancer sites and PET-CT and MRI based radiomics data and MRI linac based treatment.
  • Dr. Basu has handled over 2000 cases so far.
  • He was the recipient of the Neil Joseph Award for an observership program held at Tata Memorial Hospital, Mumbai.
  • He received the ESTRO Mobility Grant from the Institut Gustave Roussy (iGR), Paris to take part in a clinical rotation at iGR, Paris and the Orsay Proton Therapy Centre.
  • He has received a travel grant and course at Cascais, Portugal for ESO-ESTRO radiation oncology masterclass, the ESMO translational research grant from the University of Vienna and the ESMO preceptorship travel grant from Zurich and Singapore.
  • Dr. Basu completed his clinical observership in Prostate SBRT and Sarcoma Multidisciplinary management in sarcomas at the National Cancer Centre, Singapore in Dec 2018.
  • He was a Fellow of the European School of Oncology (F-ESCO).
  • He was also the recipient of the AROI-International Travel Grant.

He has more than 35 national and international publications in peer-reviewed journals and a few of them including Book Chapters.

  • Radiosurgery for Choroidal Metastases- Mini-Review. EC Ophthalmology 12.10 (2021): 54-56.
  • Preliminary Analysis of CyberKnife Stereotactic Radiotherapy for Primary and Recurrent Head and Neck Cancers: A Delicate Balance. Int J Head Neck Surg 2021;12(2):43–47.
  • Head-and-neck cancer patients beyond 2 years of disease control: Preliminary analysis of intensity-modulated radiotherapy late-effect assessment scale. J Cancer Res Ther. 2019 Jul-Sep;15(3):696-699.
  • Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single-center Data. Indian J Med Paediatr Oncol. 2017 Oct-Dec;38(4):495-501.
  • Simple diagrammatic approach to delineate duodenum on a radiotherapy planning CT scan. Br J Radiol 2016; 89: 20150661.
  • Toxicity with radiotherapy for oral cancers and its management: a practical approach. J Cancer Res Ther. 2012;8 Suppl 1:S72-84.

   Practices at

Other Doctors

HCG Call Icon